Everolimus for renal angiomyolipoma in tuberous sclerosis

Lancet. 2013 Mar 9;381(9869):783-5. doi: 10.1016/S0140-6736(12)61954-0.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiomyolipoma / drug therapy*
  • Antineoplastic Agents / therapeutic use*
  • Everolimus
  • Female
  • Humans
  • Male
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use

Substances

  • Antineoplastic Agents
  • Everolimus
  • Sirolimus